Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
5.79
-0.02 (-0.34%)
At close: May 15, 2026, 4:00 PM EDT
5.75
-0.04 (-0.69%)
After-hours: May 15, 2026, 4:10 PM EDT
Quoin Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Quoin Pharmaceuticals stock has a target of 30, which predicts a 418.13% increase from the current stock price of 5.79.
Price Target: $30 (+418.13%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Quoin Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +418.13% | May 4, 2026 |
| Maxim Group | Maxim Group | Strong Buy Maintains $525 → $140 | Strong Buy | Maintains | $525 → $140 | +2,317.96% | Mar 15, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8,400 | Strong Buy | Initiates | $8,400 | +144,977.72% | Sep 7, 2022 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $10,500 | Strong Buy | Initiates | $10,500 | +181,247.15% | May 6, 2022 |
| Maxim Group | Maxim Group | Strong Buy Initiates $26,250 | Strong Buy | Initiates | $26,250 | +453,267.88% | Jan 7, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.00
from -14.80
EPS Next Year
-4.14
from -6.00
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -4.82 | -3.31 | |
| Avg | -6.00 | -4.14 | |
| Low | -7.36 | -4.86 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.